Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis

Clicks: 305
ID: 116824
2002
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Our meta-analysis did not show a higher risk of HUS associated with antibiotic administration. A randomized trial of adequate power, with multiple distinct strains of E coli O157:H7 represented, is needed to conclusively determine whether antibiotic treatment of E coli O157:H7 enteritis increases th …
Reference Key
n2002jamarisk Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Safdar N;Said A;Gangnon RE;Maki DG;;
Journal JAMA
Year 2002
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/12190370
Keywords
meta-analysis National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't risk factors severity of illness index anti-bacterial agents / therapeutic use* enteritis / complications enteritis / microbiology* escherichia coli infections / complications* nasia safdar pmid:12190370 doi:10.1001/jama.288.8.996 adnan said dennis g maki enteritis / drug therapy escherichia coli infections / drug therapy* escherichia coli o157* hemolytic-uremic syndrome / epidemiology* hemolytic-uremic syndrome / etiology hemolytic-uremic syndrome / microbiology antibiotics infection antibiotic therapy hemolytic-uremic syndrome escherichia coli o157 enteritis

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.